Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Postmarketing Study Status Reports Need Sponsor Pre-Clearance - PhRMA

Executive Summary

Portions of postmarketing study annual status reports that will be publicly disclosed should be pre-specified by study sponsors, the Pharmaceutical Research and Manufacturers of America told FDA in Feb. 14 comments.

You may also be interested in...



Sponsors' Failure To Complete Phase IV Studies Should Draw Penalties - HRG

Public Citizen's Health Research Group is calling for FDA to seek authority to levy money penalties in cases where sponsors have failed to complete postmarketing studies requested by the agency.

Sponsors' Failure To Complete Phase IV Studies Should Draw Penalties - HRG

Public Citizen's Health Research Group is calling for FDA to seek authority to levy money penalties in cases where sponsors have failed to complete postmarketing studies requested by the agency.

Advisory Cmte. Package Redaction Could Add Two Months To Priority Review

A drug receiving six-month priority review could have its review time extended by up to two months if its sponsor requests redaction of the advisory committee package, FDA said in a draft guidance.

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel